PositiveID Corporation PSID
Moving foward, we’d like to see PSID challenge and surpass its 50DMA of .33; if it can do that, we think there is a very good chance that this multi-day runner could continue to break out.
We also whipped up a quick rundown of the PSID chart in video format for your convenience:
For those that may have missed them: The company has been reaching out to the investment community via audio interviews recently as well. Lyle Probst, President of PSID subsidiary, Microfluidic Systems, appeared on SmallCap Voice on 06/04, and CEO William Caragol gave an exclusive interview on our sister site, StockTradersTalk.com.
Mast Therapeutics, Inc. MSTX
On Friday, we included MSTX in our extended watchlist, citing that it had been gapping down to 52-week lows, and that we wanted to put it on alert for a potential bounceplay. The stock seems to have established a base here, and we still have this one on watch, as that spike off of the bottom could be significant. We want to be ready and waiting to take advantage when it does.
ACYD, BMSN, KNDI, OSH, IGLD, RNN